Stocks and Investing Stocks and Investing
Wed, May 17, 2023
Tue, May 16, 2023

Tiago Fauth Reiterated (SPRB) at Buy and Held Target at $4 on, May 16th, 2023


Published on 2024-10-28 03:49:08 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Reiterated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $4 on, May 16th, 2023.

Tiago has made no other calls on SPRB in the last 4 months.



There is 1 other peer that has a rating on SPRB. Out of the 1 peers that are also analyzing SPRB, 0 agree with Tiago's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tiago


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Thursday, March 23rd, 2023

Contributing Sources